NES
CLB icon

New England Securities’s Core Laboratories CLB Stock Holding History

New England Securities’s Portfolio CLB Stock Details CLB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-14
Closed -$2K – 1645
2013
Q3 		$2K Hold
14
– – ﹤0.01% 1405
2013
Q2 		$2K Buy
+14
New +$1.98K ﹤0.01% 1243

Other funds holding CLB

Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
CG
Carmignac Gestion Paris, France $6.51B AUM 19.13% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
WI
WHV Investments San Francisco, California $187M AUM 14.29% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
VAM
Vontobel Asset Management New York $18.1B AUM 28.09% 1-Year Est. Return

New England Securities's CLB Position: Q4 2013 in Review

New England Securities sold out of Core Laboratories (CLB) in Q4 2013, closing a stake of 14 shares — an estimated $2K sold.

New England Securities first reported a position in CLB in Q2 2013 and held it in 2 quarters. The position peaked at $2K in Q3 2013. 345 funds tracked by Wall St. Rank hold CLB as of Q4 2013.

  • New England Securities reported no remaining Core Laboratories position as of Q4 2013 after selling out during the quarter.
  • New England Securities sold 14 Core Laboratories shares in Q4 2013, an estimated $2K.
  • New England Securities first reported a position in Core Laboratories in Q2 2013 and held it in 2 quarters.
  • New England Securities's Core Laboratories position peaked at $2K in Q3 2013.
  • 345 funds tracked by Wall St. Rank held Core Laboratories as of Q4 2013.

Based on New England Securities's 13F filing for Q4 2013, filed 31 Jan 2014.